Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents
dc.contributor.author | Hood, Korey K. | |
dc.contributor.author | Garcia-Willingham, Natasha | |
dc.contributor.author | Hanes, Sarah | |
dc.contributor.author | Tanenbaum, Molly L. | |
dc.contributor.author | Ware, Julia | |
dc.contributor.author | Boughton, Charlotte K. | |
dc.contributor.author | Allen, Janet M. | |
dc.contributor.author | Wilinska, Malgorzata E. | |
dc.contributor.author | Tauschmann, Martin | |
dc.contributor.author | Denvir, Louise | |
dc.contributor.author | Thankamony, Ajay | |
dc.contributor.author | Campbell, Fiona | |
dc.contributor.author | Wadwa, R. Paul | |
dc.contributor.author | Buckingham, Bruce A. | |
dc.contributor.author | Davis, Nikki | |
dc.contributor.author | DiMeglio, Linda A. | |
dc.contributor.author | Mauras, Nelly | |
dc.contributor.author | Besser, Rachel E. J. | |
dc.contributor.author | Ghatak, Atrayee | |
dc.contributor.author | Weinzimer, Stuart A. | |
dc.contributor.author | Fox, D. Steven | |
dc.contributor.author | Kanapka, Lauren | |
dc.contributor.author | Kollman, Craig | |
dc.contributor.author | Sibayan, Judy | |
dc.contributor.author | Beck, Roy W. | |
dc.contributor.author | Hovorka, Roman | |
dc.contributor.department | DAN05 Consortium | |
dc.date.accessioned | 2023-10-23T12:24:33Z | |
dc.date.available | 2023-10-23T12:24:33Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Aim: To examine changes in the lived experience of type 1 diabetes after use of hybrid closed loop (CL), including the CamAPS FX CL system. Materials and methods: The primary study was conducted as an open-label, single-period, randomized, parallel design contrasting CL versus insulin pump (with or without continuous glucose monitoring). Participants were asked to complete patient-reported outcomes before starting CL and 3 and 6 months later. Surveys assessed diabetes distress, hypoglycaemia concerns and quality of life. Qualitative focus group data were collected at the completion of the study. Results: In this sample of 98 youth (age range 6-18, mean age 12.7 ± 2.8 years) and their parents, CL use was not associated with psychosocial benefits overall. However, the subgroup (n = 12) using the CamAPS FX system showed modest improvements in quality of life and parent distress, reinforced by both survey (p < .05) and focus group responses. There were no negative effects of CL use reported by study participants. Conclusions: Closed loop use via the CamAPS FX system was associated with modest improvements in aspects of the lived experience of managing type 1 diabetes in youth and their families. Further refinements of the system may optimize the user experience. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Hood KK, Garcia-Willingham N, Hanes S, et al. Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents. Diabetes Obes Metab. 2022;24(12):2309-2318. doi:10.1111/dom.14815 | |
dc.identifier.uri | https://hdl.handle.net/1805/36549 | |
dc.language.iso | en_US | |
dc.publisher | Wiley | |
dc.relation.isversionof | 10.1111/dom.14815 | |
dc.relation.journal | Diabetes, Obesity & Metabolism | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | PMC | |
dc.subject | Blood glucose | |
dc.subject | Blood glucose self-monitoring | |
dc.subject | Type 1 diabetes mellitus | |
dc.subject | Hypoglycemic agents | |
dc.subject | Insulin | |
dc.subject | Treatment outcome | |
dc.title | Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents | |
dc.type | Article |